These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11278846)

  • 1. Selective suppression of CCAAT/enhancer-binding protein beta binding and cyclooxygenase-2 promoter activity by sodium salicylate in quiescent human fibroblasts.
    Saunders MA; Sansores-Garcia L; Gilroy DW; Wu KK
    J Biol Chem; 2001 Jun; 276(22):18897-904. PubMed ID: 11278846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin and other cyclooxygenase inhibitors: new therapeutic insights.
    Wu KK
    Semin Vasc Med; 2003 May; 3(2):107-12. PubMed ID: 15199473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acid.
    Mitchell JA; Saunders M; Barnes PJ; Newton R; Belvisi MG
    Mol Pharmacol; 1997 Jun; 51(6):907-12. PubMed ID: 9187256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate.
    Xu XM; Sansores-Garcia L; Chen XM; Matijevic-Aleksic N; Du M; Wu KK
    Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5292-7. PubMed ID: 10220459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of COX-2 and iNOS gene expressions by aspirin and salicylate.
    Wu KK
    Thromb Res; 2003 Jun; 110(5-6):273-6. PubMed ID: 14592547
    [No Abstract]   [Full Text] [Related]  

  • 6. Dynamic regulation of cyclooxygenase-2 promoter activity by isoforms of CCAAT/enhancer-binding proteins.
    Zhu Y; Saunders MA; Yeh H; Deng WG; Wu KK
    J Biol Chem; 2002 Mar; 277(9):6923-8. PubMed ID: 11741938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salicylate suppresses macrophage nitric-oxide synthase-2 and cyclo-oxygenase-2 expression by inhibiting CCAAT/enhancer-binding protein-beta binding via a common signaling pathway.
    Cieslik K; Zhu Y; Wu KK
    J Biol Chem; 2002 Dec; 277(51):49304-10. PubMed ID: 12379662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of interleukin-1beta-induced COX-2 and EP3 gene expression by sodium salicylate enhances pancreatic islet beta-cell function.
    Tran PO; Gleason CE; Robertson RP
    Diabetes; 2002 Jun; 51(6):1772-8. PubMed ID: 12031964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2.
    Gallois C; Habib A; Tao J; Moulin S; Maclouf J; Mallat A; Lotersztajn S
    J Biol Chem; 1998 Sep; 273(36):23183-90. PubMed ID: 9722548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-IL6 and CRE elements principally account for both basal and interleukin-1 beta-induced transcriptional activity of the proximal 528bp of the PGHS-2 promoter in amnion-derived AV3 cells: evidence for involvement of C/EBP beta.
    Potter S; Mitchell MD; Hansen WR; Marvin KW
    Mol Hum Reprod; 2000 Sep; 6(9):771-8. PubMed ID: 10956548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin and salicylate: An old remedy with a new twist.
    Wu KK
    Circulation; 2000 Oct; 102(17):2022-3. PubMed ID: 11044413
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of p90 ribosomal S6 kinase-mediated CCAAT/enhancer-binding protein beta activation and cyclooxygenase-2 expression by salicylate.
    Cieslik KA; Zhu Y; Shtivelband M; Wu KK
    J Biol Chem; 2005 May; 280(18):18411-7. PubMed ID: 15738002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of lipopolysaccharide-inducible cyclooxygenase 2 expression by C2-ceramide via c-Jun N-terminal kinase-mediated activation of CCAAT/enhancer binding protein beta in macrophages.
    Cho YH; Lee CH; Kim SG
    Mol Pharmacol; 2003 Mar; 63(3):512-23. PubMed ID: 12606757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium salicylate inhibits expression of COX-2 through suppression of ERK and subsequent NF-kappaB activation in rat ventricular cardiomyocytes.
    Kwon KS; Chae HJ
    Arch Pharm Res; 2003 Jul; 26(7):545-53. PubMed ID: 12934647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer.
    Wong BC; Jiang Xh; Fan XM; Lin MC; Jiang SH; Lam SK; Kung HF
    Oncogene; 2003 Feb; 22(8):1189-97. PubMed ID: 12606945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
    Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J
    Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S; Inoue H; Flowers LC; Sidell N
    Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salicylate metabolites inhibit cyclooxygenase-2-dependent prostaglandin E(2) synthesis in murine macrophages.
    Hinz B; Kraus V; Pahl A; Brune K
    Biochem Biophys Res Commun; 2000 Jul; 274(1):197-202. PubMed ID: 10903918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tumor necrosis factor alpha-induced prostaglandin E2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: distinct targeting in the signaling pathways.
    Alaaeddine N; Di Battista JA; Pelletier JP; Kiansa K; Cloutier JM; Martel-Pelletier J
    Arthritis Rheum; 1999 Apr; 42(4):710-8. PubMed ID: 10211885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugated polyhydroxybenzene derivatives block tumor necrosis factor-alpha-mediated nuclear factor-kappaB activation and cyclooxygenase-2 gene transcription by targeting IkappaB kinase activity.
    Chen CC; Chiu KT; Chan ST; Chern JW
    Mol Pharmacol; 2001 Dec; 60(6):1439-48. PubMed ID: 11723253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.